Skip to main content

Table 3 Yearly expected costs per patient by treatment and by time period, BAT + GDT vs. GDT alone, 2018 US Dollars (HF hospitalization rate relative reduction = 25%)

From: Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States

Time period (a) BAT + GDT GDT Alone Difference
1 Year $53,141 $28,093 $25,047
2 Years $14,184 $21,049 $(6,865)
3 Years $9,541 $31,602 ($22,061)
  1. (a) time period is marked by the implantation of the BAT device; 6-month data pertains to the BeAT-HF clinical trial, whereas years 1, 2 and 3 are based on extrapolations (see text)